On Invalid Date, Ekso Bionics Holdings (NASDAQ: EKSO) reported Q4 2023 earnings per share (EPS) of -$0.22, up 8.33% year over year. Total Ekso Bionics Holdings earnings for the quarter were -$3.21 million. In the same quarter last year, Ekso Bionics Holdings's earnings per share (EPS) was -$0.24.
As of Q1 2024, Ekso Bionics Holdings's earnings has grown year over year. Ekso Bionics Holdings's earnings in the past year totalled -$15.20 million.
What is EKSO's earnings date?
Ekso Bionics Holdings's earnings date is Invalid Date. Add EKSO to your watchlist to be reminded of EKSO's next earnings announcement.
What was EKSO's revenue last quarter?
On Invalid Date, Ekso Bionics Holdings (NASDAQ: EKSO) reported Q4 2023 revenue of $4.85 million up 36.5% year over year. In the same quarter last year, Ekso Bionics Holdings's revenue was $3.55 million.
What was EKSO's revenue growth in the past year?
As of Q1 2024, Ekso Bionics Holdings's revenue has grown 41.57% year over year. This is 33.56 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 8.01%. Ekso Bionics Holdings's revenue in the past year totalled $18.28 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.